Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk scorePhilip L. De Jager, Elizabeth W. Karlson, Lori B. Chibnik et al.|The Lancet Neurology|2009Cited by 268
Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trialDaniel S. Reich, Sibyl Wray, Robert J. Fox et al.|The Lancet Neurology|2021Cited by 192